Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) is a member of the interleukin-1 receptor family distinguished by its selective and high expression in the brain. Unlike canonical interleukin-1 receptor accessory proteins that mediate immune or inflammatory signaling, IL1RAPL1 does not participate in immune signaling but instead plays an essential role in nervous system development by organizing synapse formation and neuronal connectivity. Mutations or deletions in the IL1RAPL1 gene are causative for X-linked intellectual disability and may also contribute to neurodevelopmental disorders such as autism. The protein contains three immunoglobulin (Ig)-like domains in its extracellular region and is also known as Oligophrenin-4[2][6][7]. It mediates trans-synaptic cell adhesion and is critical for normal synaptic function and neural signaling in the human brain.
Not applicable, as there are no drugs directly targeting this protein. Gene loss or mutation results in loss of function in neural synapse organization, but no targeted pharmacological mechanism is established[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1).